The application of medical decision analysis to genetic testing: An introduction

被引:20
作者
McConnell, LM
Goldstein, MK
机构
[1] Stanford Program Genom Eth & Soc, Palo Alto, CA 94304 USA
[2] Vet Affairs Palo Alto Hlth Care Syst, Hlth Sev Res & Policy, Palo Alto, CA 94304 USA
[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源
GENETIC TESTING | 1999年 / 3卷 / 01期
关键词
D O I
10.1089/gte.1999.3.65
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The availability of genetic tests to diagnose or predict Alzheimer disease (AD) causes a shift in the way people think about the condition and how they assess the options available to them, Decision analysis is a quantitative approach for dealing with the uncertainties inherent in many medical decisions, including decisions about genetic testing. Decision analysis does not guarantee a good outcome, but aims to yield better overall average results by providing a framework for people to evaluate their options and minimize cognitive biases. We provide an overview of the decision analysis process, including the terms and tools commonly associated with it. We also use a recent example to demonstrate one way decision analysis has been applied to genetics in the medical literature. This paper is an introduction to subsequent papers that explore the specific question of whether decision analysis is a helpful tool for understanding the uncertainty inherent in probabilistic information about genetic risk for AD.
引用
收藏
页码:65 / 70
页数:6
相关论文
共 29 条
[1]  
[Anonymous], 1988, CLIN CHEM
[2]   Decision analysis in locally advanced non-small-cell lung cancer: Is it useful? [J].
Brundage, MD ;
Groome, PA ;
FeldmanStewart, D ;
Davidson, JR ;
Mackillop, WJ .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :873-883
[3]  
Clemen RT, 1991, MAKING HARD DECISION
[4]   COMPARISON OF PHYSICIANS DECISIONS REGARDING ESTROGEN REPLACEMENT THERAPY FOR MENOPAUSAL WOMEN AND DECISIONS DERIVED FROM A DECISION ANALYTIC MODEL [J].
ELSTEIN, AS ;
HOLZMAN, GB ;
RAVITCH, MM ;
METHENY, WA ;
HOLMES, MM ;
HOPPE, RB ;
ROTHERT, ML ;
ROVNER, DR .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (02) :246-258
[5]  
Fleming C, 1993, JAMA, V269, P2650
[6]   COST-EFFECTIVENESS OF WARFARIN AND ASPIRIN FOR PROPHYLAXIS OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION [J].
GAGE, BF ;
CARDINALLI, AB ;
ALBERS, GW ;
OWENS, DK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (23) :1839-1845
[7]  
Hagen M D, 1992, Fam Med, V24, P349
[8]   EFFICACY AND COST-EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN WOMEN WITH NODE-NEGATIVE BREAST-CANCER - A DECISION-ANALYSIS MODEL [J].
HILLNER, BE ;
SMITH, TJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (03) :160-168
[9]   Decision analysis and Alzheimer disease: Three case studies [J].
Holtzman, S ;
Ozanne, E ;
Carone, B ;
Goldstein, MK ;
Steinke, G ;
Timbs, J .
GENETIC TESTING, 1999, 3 (01) :71-83
[10]  
HOWARD RA, 1984, MANAGE SCI, V30, P547